Catalyst Wire Dossier Catalyst Wire Dossier

StroMel

· Akan Biosciences, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for StroMel, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint [Phase 1, Phase 2]

See pricing